Mineralys at Stifel Forum: Lorundrostat's Strategic Path
PositiveFinancial Markets

Mineralys recently presented at the Stifel Forum, outlining the strategic path for lorundrostat, a promising treatment for hypertension. This event is significant as it highlights the company's commitment to advancing innovative therapies that could improve patient outcomes and address a critical health issue.
— Curated by the World Pulse Now AI Editorial System